ReviewBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2023

Do the Outcomes of Clinical Efficacy Trials Matter in Regulatory Decision-Making for Biosimilars?

Nadine Kirsch-Stefan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.